TSO3 Company Contact: TSO3, Inc., R.M. (Ric) Rumble, President and CEO, Tel: 418 651-0003, Email: info@tso3.com; TSO3 Investor Relations: Liolios Group, Inc., Chris Tyson, Tel: 949 574-3860, TOS@liolios.com; Getinge Contact: Healthcare - Getinge USA Inc., US Headquarters, 1777 East Henrietta Road, Rochester, NY 14623, 1 800 475 9040Copyright CNW Group 2015
TSO3 and GETINGE Infection Control Sign Exclusive Global Distribution Agreement
On 6ix: 6ix.com/news/tso3-and-getinge-infection-control-sign-exclusive-global-distribution-agreement
View original source (CNW)TSO3 Inc on 6ix
Earlier from TSO3
- TSO3 Appoints Steve West to Board of Directors
- TSO3 Reports Third Quarter 2015 Financial Results
- TSO3 Allowed Expanded Claims for Revolutionary STERIZONE® VP4 Sterilizer
- TSO3: Q3 2015 Financial Results Conference Call
- TSO3 Engages Liolios Group to Lead New Strategic Investor Relations Program
Later from TSO3
- TSO3 Establishes Medical Industry's First-Ever Claims for Duodenoscope Terminal Sterilization
- TSO3 Appoints Glen Kayll as Chief Financial Officer
- TSO3 to Expand Manufacturing Workforce to Meet Demand for STERIZONE® VP4 Sterilizer
- TSO3 Completes Additional Studies, Files Extended U.S. Claims for Breakthrough Medical Device Sterilizer
- TSO3 Accelerates Warrant Expiry Date
Follow TSO3 into a list and get an email when it puts out news.
Follow TSO3